Skip navigation
logo
(AFX UK Focus) 2009-08-24 15:37
BRIEF-US FDA sets panel meetings on Glaxo, Schering-Plough, other drugs
Article layout: raw

WASHINGTON, Aug 24 (Reuters) - The U.S. Food and Drug Administration, in notices released on Monday, said:

  • SETS OCTOBER 14 ADVISORY PANEL MEETING ON ACORDA THERAPEUTICS INC'S
    proposed multiple sclerosis drug Amaya

  • SETS OCTOBER 5 MEETING ON PROPOSED GLAXOSMITHKLINE PLC DRUG
    Votrient for kidney cancer

  • PANEL ALSO TO DISCUSS SCHERING-PLOUGH CORP'S PEGINTRON
    for use in addition to surgery for melanoma at October 5 meeting

  • SETS SEPTEMBER 24 ADVISORY PANEL MEETING ON PURDUE PHARMA'S OXYCONTIN
    controlled release tablets

  • OXYCONTIN FORMULATION WAS REVIEWED AT MAY 5, 2008 MEETING, WILL BE CONSIDERED
    again 'in light of new data'

  • SETS OCTOBER 6 ADVISORY PANEL MEETING ON APOPHARMA INC'S PROPOSED IRON
    overload drug Ferriprox

    (Company news desk in Washington; +1 202 898 8400, washington.newsroom@reuters.com)

    COPYRIGHT

    Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

    		•
    Re-organisations, re-structurings, name changes, AGM, EGM
    Government ministries
    General news
    Political news
    Article layout: raw
    Jump back to site navigation